Unsubstantiated claims of effective antibiotic use may induce shortages.

This influential review article suggests a shift in, but no cessation of, RA therapy.

Given serious and potentially deadly risks, identification of risk factors is crucial.

Improved surveillance needed.

Una metanalisi richiama l’attenzione sull’uso indiscriminato di inibitori di pompa protonica.

Results held robust through sensitivity analyses.

A pocket card helped cut vancomycin orders for patients headed home.

Scientific advances and remarkable accomplishments in 2019 for tuberculosis research.

10 studies highlight areas of risk for unneeded care, patient harm.

Positive association disappears with sibling, twin analyses.

Timely diagnosis is needed.

Consider additional resistance screening among MSM who test positive.

Ancora in troppi casi negli Stati Uniti i farmaci sono dati senza indicazioni documentate.

Treatment response may be delayed.